Stockscreener 앱 받기
6.20
1.81%
0.11
시간 외 거래:
6.20
전일 마감가:
$6.09
열려 있는:
$6.09
하루 거래량:
374.30K
Relative Volume:
0.77
시가총액:
$312.42M
수익:
$230.47M
순이익/손실:
$30.28M
주가수익비율:
10.16
EPS:
0.61
순현금흐름:
$38.86M
1주 성능:
+4.20%
1개월 성능:
+14.81%
6개월 성능:
+72.70%
1년 성능:
+74.65%
1일 변동 폭
$5.97
$6.29
1주일 범위
$5.635
$6.29
52주 변동 폭
$2.575
$6.29
Puma Biotechnology Inc Stock (PBYI) Company Profile
명칭
Puma Biotechnology Inc
전화
(424) 248-6500
주소
10880 WILSHIRE BLVD., LOS ANGELES, CA
PBYI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
6.20 | 306.88M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-09-28 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-25 | 재개 | BofA/Merrill | Underperform |
| 2019-10-08 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-05-10 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-01-17 | 개시 | Leerink Partners | Mkt Perform |
| 2019-01-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2018-11-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-11-02 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-10-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-09-17 | 개시 | Goldman | Sell |
| 2018-05-11 | 재확인 | Stifel | Buy |
| 2017-11-10 | 재확인 | Citigroup | Buy |
| 2017-11-10 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | 재확인 | Stifel | Buy |
| 2017-09-11 | 재확인 | Credit Suisse | Outperform |
| 2017-07-10 | 재개 | Leerink Partners | Outperform |
| 2017-06-06 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | 재확인 | RBC Capital Mkts | Sector Perform |
모두보기
Puma Biotechnology Inc 주식(PBYI)의 최신 뉴스
Will Puma Biotechnology Inc. stock keep outperforming rivalsWeekly Trade Recap & High Accuracy Swing Trade Signals - ulpravda.ru
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Puma Biotechnology reports inducement awards under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Up 91% in the Past Year, Is This Biotech Stock Red Hot or a Red Flag? - Yahoo Finance
Puma Biotechnology (NASDAQ:PBYI) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - sharewise.com
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) - BioSpace
Puma Biotechnology Added to Nasdaq Biotechnology Index - marketscreener.com
If EPS Growth Is Important To You, Puma Biotechnology (NASDAQ:PBYI) Presents An Opportunity - Yahoo Finance
How Puma Biotechnology Inc. stock reacts to oil pricesPortfolio Value Report & Low Risk High Reward Trade Ideas - Улправда
What dividend safety score for Puma Biotechnology Inc. stockJuly 2025 Momentum & Long-Term Growth Portfolio Plans - Улправда
What analyst consensus says on Puma Biotechnology Inc. stock2025 Buyback Activity & Expert Curated Trade Setups - Улправда
History Review: How Puma Biotechnology Inc. stock reacts to oil pricesWeekly Risk Report & AI Driven Stock Reports - Улправда
CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy? - TradingView — Track All Markets
Why analysts upgrade Puma Biotechnology Inc stock2025 Winners & Losers & Consistent Income Trade Ideas - moha.gov.vn
Puma Biotechnology Earnings Notes - Trefis
Acorn Capital Advisors LLC Has $14.17 Million Stake in Puma Biotechnology, Inc. $PBYI - MarketBeat
With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case - Sahm
American Century Companies Inc. Grows Stake in Puma Biotechnology, Inc. $PBYI - MarketBeat
What analysts say about Puma Biotechnology Inc stockStock Liquidity Analysis & Minimal Investment Capital Gains - earlytimes.in
Can Puma Biotechnology Stock Hold Up When Markets Turn? - Trefis
What insider trading reveals about Puma Biotechnology Inc. stock2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Puma Biotechnology (NASDAQ:PBYI) Stock Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
With 60% ownership of the shares, Puma Biotechnology, Inc. (NASDAQ:PBYI) is heavily dominated by institutional owners - Yahoo Finance
Puma Biotechnology, Inc. (PBYI) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? - MSN
Total debt per share of Puma Biotechnology, Inc. – TRADEGATE:0PB - TradingView
Check out these key findings about Puma Biotechnology Inc (PBYI) - Setenews
Hillsdale Investment Management Inc. Makes New Investment in Puma Biotechnology, Inc. $PBYI - MarketBeat
Will Puma Biotechnology Inc. stock continue upward momentumGDP Growth & AI Forecast Swing Trade Picks - newser.com
Is Puma Biotechnology Inc. stock affected by interest rate hikes2025 Earnings Impact & Real-Time Volume Surge Alerts - newser.com
Using Ichimoku Cloud for Puma Biotechnology Inc. technicalsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Using data filters to optimize entry into Puma Biotechnology Inc.July 2025 Drop Watch & Intraday High Probability Alerts - newser.com
Published on: 2025-11-19 05:37:08 - newser.com
Puma Biotechnology Inc (PBYI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
4.56%
자본화:
|
볼륨(24시간):